NCT03876951View on ClinicalTrials.gov

Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)

NAActive, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

February 28, 2025

Study Completion Date

April 8, 2025

Conditions
Vacuum-assisted Biopsy
Interventions
DIAGNOSTIC_TEST

Vacuum-assisted biopsy

Patients will be submitted to percutaneous vacuum-assisted biopsy (VAB), followed by breast surgery.

Trial Locations (1)

21000

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT03876951 - Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB) | Biotech Hunter | Biotech Hunter